Literature DB >> 33746979

Second Report of Chronic Granulomatous Disease in Jordan: Clinical and Genetic Description of 31 Patients From 21 Different Families, Including Families From Lybia and Iraq.

Faris Ghalib Bakri1,2, Michelle Mollin3, Sylvain Beaumel3, Bénédicte Vigne3, Nathalie Roux-Buisson4,5, Adel Mohammed Al-Wahadneh6, Raed Mohammed Alzyoud6, Wail Ahmad Hayajneh7, Ammar Khaled Daoud8, Mohammed Elian Abu Shukair9, Mansour Fuad Karadshe10, Mahmoud Mohammad Sarhan11, Jamal Ahmad Wadi Al-Ramahi12, Julien Fauré4,5, John Rendu4,5, Marie Jose Stasia3,13.   

Abstract

Chronic granulomatous Disease (CGD) is a rare innate immunodeficiency disorder caused by mutations in one of the six genes (CYBA, CYBB, NCF1, NCF2, NCF4, and CYBC1/EROS) encoding the superoxide-producing nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase complex in phagocytes. In the Western population, the most prevalent form of CGD (about two-thirds of all cases) is the X-linked form (X-CGD) caused by mutations in CYBB. The autosomal recessive forms (AR-CGD), due to mutations in the other genes, collectively account for the remaining one-third of CGD cases. We investigated the clinical and molecular features of 22 Jordanian, 7 Libyan, and 2 Iraqi CGD patients from 21 different families. In addition, 11 sibling patients from these families were suspected to have been died from CGD as suggested by their familial and clinical history. All patients except 9 were children of consanguineous parents. Most of the patients suffered from AR-CGD, with mutations in CYBA, NCF1, and NCF2, encoding p22 phox , p47 phox , and p67 phox proteins, respectively. AR-CGD was the most frequent form, in Jordan probably because consanguineous marriages are common in this country. Only one patient from non-consanguineous parents suffered from an X910 CGD subtype (0 indicates no protein expression). AR670 CGD and AR220 CGD appeared to be the most frequently found sub-types but also the most severe clinical forms compared to AR470 CGD. As a geographical clustering of 11 patients from eight Jordanian families exhibited the c.1171_1175delAAGCT mutation in NCF2, segregation analysis with nine polymorphic markers overlapping NCF2 indicates that a common ancestor has arisen ~1,075 years ago.
Copyright © 2021 Bakri, Mollin, Beaumel, Vigne, Roux-Buisson, Al-Wahadneh, Alzyoud, Hayajneh, Daoud, Shukair, Karadshe, Sarhan, Al-Ramahi, Fauré, Rendu and Stasia.

Entities:  

Keywords:  Jordan; NADPH oxidase; autosomal recessive; chronic granulomatous disease; founder mutation; innate immunodeficiency

Year:  2021        PMID: 33746979      PMCID: PMC7973097          DOI: 10.3389/fimmu.2021.639226

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  74 in total

1.  Jordan: communities and community genetics.

Authors:  Hanan Hamamy; Sana Al-Hait; Aladin Alwan; Kamel Ajlouni
Journal:  Community Genet       Date:  2007

2.  A conserved region between the TPR and activation domains of p67phox participates in activation of the phagocyte NADPH oxidase.

Authors:  Yuichi Maehara; Kei Miyano; Satoru Yuzawa; Risa Akimoto; Ryu Takeya; Hideki Sumimoto
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

3.  Clinical, Immunological, and Molecular Findings of Patients with p47phox Defect Chronic Granulomatous Disease (CGD) in Indian Families.

Authors:  Manasi Kulkarni; Mukesh Desai; Maya Gupta; Aparna Dalvi; Prasad Taur; Antony Terrance; Sunil Bhat; Mamta Manglani; Revathi Raj; Ira Shah; Manisha Madkaikar
Journal:  J Clin Immunol       Date:  2016-10-03       Impact factor: 8.317

4.  Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.

Authors:  Mustafa Yavuz Köker; Yıldız Camcıoğlu; Karin van Leeuwen; Sara Şebnem Kılıç; Işıl Barlan; Mustafa Yılmaz; Ayşe Metin; Martin de Boer; Hüseyin Avcılar; Türkan Patıroğlu; Alişan Yıldıran; Olcay Yeğin; Ilhan Tezcan; Özden Sanal; Dirk Roos
Journal:  J Allergy Clin Immunol       Date:  2013-07-31       Impact factor: 10.793

5.  First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families.

Authors:  Faris G Bakri; Cécile Martel; Najwa Khuri-Bulos; Azmi Mahafzah; Mohammad S El-Khateeb; Adel M Al-Wahadneh; Wail A Hayajneh; Hanan A Hamamy; Elisabeth Maquet; Michelle Molin; Marie José Stasia
Journal:  J Clin Immunol       Date:  2008-09-05       Impact factor: 8.317

6.  Inherited p40phox deficiency differs from classic chronic granulomatous disease.

Authors:  Annemarie van de Geer; Alejandro Nieto-Patlán; Douglas B Kuhns; Anton Tj Tool; Andrés A Arias; Matthieu Bouaziz; Martin de Boer; José Luis Franco; Roel P Gazendam; John L van Hamme; Michel van Houdt; Karin van Leeuwen; Paul Jh Verkuijlen; Timo K van den Berg; Juan F Alzate; Carlos A Arango-Franco; Vritika Batura; Andrea R Bernasconi; Barbara Boardman; Claire Booth; Siobhan O Burns; Felipe Cabarcas; Nadine Cerf Bensussan; Fabienne Charbit-Henrion; Anniek Corveleyn; Caroline Deswarte; María Esnaola Azcoiti; Dirk Foell; John I Gallin; Carlos Garcés; Margarida Guedes; Claas H Hinze; Steven M Holland; Stephen M Hughes; Patricio Ibañez; Harry L Malech; Isabelle Meyts; Marcela Moncada-Velez; Kunihiko Moriya; Esmeralda Neves; Matias Oleastro; Laura Perez; Vimel Rattina; Carmen Oleaga-Quintas; Neil Warner; Aleixo M Muise; Jeanet Serafín López; Eunice Trindade; Julia Vasconcelos; Séverine Vermeire; Helmut Wittkowski; Austen Worth; Laurent Abel; Mary C Dinauer; Peter D Arkwright; Dirk Roos; Jean-Laurent Casanova; Taco W Kuijpers; Jacinta Bustamante
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

7.  Chronic granulomatous disease: two decades of experience from a tertiary care centre in North West India.

Authors:  Amit Rawat; Surjit Singh; Deepti Suri; Anju Gupta; Biman Saikia; Ranjana Walker Minz; Shobha Sehgal; Kim Vaiphei; C Kamae; K Honma; N Nakagawa; K Imai; S Nonoyama; K Oshima; N Mitsuiki; O Ohara; Koon-Wing Chan; Yu Lung Lau
Journal:  J Clin Immunol       Date:  2013-11-26       Impact factor: 8.317

8.  Consanguinity and genetic disorders. Profile from Jordan.

Authors:  Hanan A Hamamy; Amira T Masri; Azmy M Al-Hadidy; Kamel M Ajlouni
Journal:  Saudi Med J       Date:  2007-07       Impact factor: 1.484

9.  Clinical, functional and genetic characterization of 16 patients suffering from chronic granulomatous disease variants - identification of 11 novel mutations in CYBB.

Authors:  M Mollin; S Beaumel; B Vigne; J Brault; N Roux-Buisson; J Rendu; V Barlogis; G Catho; C Dumeril; F Fouyssac; D Monnier; V Gandemer; M Revest; J-P Brion; C Bost-Bru; E Jeziorski; L Eitenschenck; C Jarrasse; S Drillon Haus; M Houachée-Chardin; M Hancart; G Michel; Y Bertrand; D Plantaz; J Kelecic; R Traberg; L Kainulainen; J Fauré; F Fieschi; M J Stasia
Journal:  Clin Exp Immunol       Date:  2020-10-12       Impact factor: 4.330

10.  Genetic, Immunological, and Clinical Features of the First Mexican Cohort of Patients with Chronic Granulomatous Disease.

Authors:  Lizbeth Blancas-Galicia; Eros Santos-Chávez; Caroline Deswarte; Quentin Mignac; Isabel Medina-Vera; Ximena León-Lara; Manon Roynard; Selma C Scheffler-Mendoza; Ricardo Rioja-Valencia; Alexandra Alvirde-Ayala; Saul O Lugo Reyes; Tamara Staines-Boone; Jorge García-Campos; Omar J Saucedo-Ramírez; Blanca E Del-Río Navarro; Antonio Zamora-Chávez; Arturo López-Larios; Susana García-Pavón-Osorio; Eugenia Melgoza-Arcos; María R Canseco-Raymundo; Dolores Mogica-Martínez; Marco Venancio-Hernández; Daniel Pacheco-Rosas; Sigifredo Pedraza-Sánchez; Martha Guevara-Cruz; Federico Saracho-Weber; Berenise Gámez-González; Guillermo Wakida-Kuzunoki; Ana R Morán-Mendoza; Ana P Macías-Robles; Roselia Ramírez-Rivera; Eugenia Vargas-Camaño; Carmen Zarate-Hernández; Héctor Gómez-Tello; Emmanuel Ramírez-Sánchez; Fredy Ruíz-Hernández; Domingo Ramos-López; Héctor Acuña-Martínez; María L García-Cruz; María G Román-Jiménez; Marina G González-Villarreal; Aristóteles Álvarez-Cardona; Beatriz A Llamas-Guillén; Jennifer Cuellar-Rodríguez; Alberto Olaya-Vargas; Nideshda Ramírez-Uribe; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova; Francisco J Espinosa-Rosales; Jeanet Serafín-López; Marco Yamazaki-Nakashimada; Sara Espinosa-Padilla; Jacinta Bustamante
Journal:  J Clin Immunol       Date:  2020-02-10       Impact factor: 8.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.